# 119-s-1097: Interagency Patent Coordination and Improvement Act of 2025

119-s-1097, Interagency Patent Coordination and Improvement Act of 2025, is a 119th Congress bill sponsored by Sen. Durbin, Richard J. [D-IL] (D-IL); status in_committee (as of 2026-08-11).

- Canonical: https://policyrisk.com/legislation/119-s-1097
- As of: 2026-08-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-s-1097
- Congress: 119
- Title: Interagency Patent Coordination and Improvement Act of 2025
- Status: in_committee
- Introduced: 2025-03-24
- Sponsor: Sen. Durbin, Richard J. [D-IL] (D-IL)
- Cosponsors: 4
- Policy area: Commerce
- Touches household money: no
- Last recorded action: 2026-08-11

## Summary

**Stronger USPTO–FDA coordination on patents for human drugs and biological products.** This bill would create an Interagency Task Force on Patents to share technical and approval information, set a formal process for USPTO requests to the Food and Drug Administration, and have the USPTO assist the FDA with patent listings. - Patent examiners would get access to FDA materials relevant to drug and biologic approvals, including product applications, labeling updates, and select nonpublic communications when appropriate to improve examination of prior art and on‑sale issues. - Establishes a statutory Task Force with members from both agencies, a required memorandum of understanding, routine meetings, training, and a required report to the Judiciary Committees within four years on how often FDA information is used and what methods are most useful. - Drug and biologic sponsors would get confidentiality safeguards that mirror FDA protections, a notice and 30‑day consultation period before nonpublic information is shared, and procedures for remedies after any inadvertent disclosure.

## Cosponsors (4)

- Sen. Tillis, Thomas [R-NC] (R-NC), 2025-03-24T00:00:00.000Z
- Sen. Grassley, Chuck [R-IA] (R-IA), 2025-03-24T00:00:00.000Z
- Sen. Coons, Christopher A. [D-DE] (D-DE), 2025-03-24T00:00:00.000Z
- Sen. Welch, Peter [D-VT] (D-VT), 2025-03-24T00:00:00.000Z

## Provisions PRIA read

- New patent task force for drugmakers: benefit, low. This bill would create a new USPTO–FDA Interagency Task Force for patents on human drugs and biologics. The Director and the FDA Commissioner would enter or update a memorandum of understanding and the USPTO Director would consult the FDA through the task force when handling these patents. The task…

## Related bills

- 119-s-1748: Kids Online Safety Act
- 119-s-1241: Sanctioning Russia Act of 2025
- 119-s-1884: Holocaust Expropriated Art Recovery Act of 2025
- 119-s-3966: TREY'S Law
- 119-s-825: Fighting Post-Traumatic Stress Disorder Act of 2025
- 119-sres-913: A resolution relating to the death of the Honorable Nancy Kassebaum, former United States Senator for the State of Kansas.

## Sources
- [119-s-1097 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/1097)

## Related
- [119-s-1748: Kids Online Safety Act](https://policyrisk.com/legislation/119-s-1748)
- [119-s-1241: Sanctioning Russia Act of 2025](https://policyrisk.com/legislation/119-s-1241)
- [119-s-1884: Holocaust Expropriated Art Recovery Act of 2025](https://policyrisk.com/legislation/119-s-1884)
- [119-s-3966: TREY'S Law](https://policyrisk.com/legislation/119-s-3966)
- [119-s-825: Fighting Post-Traumatic Stress Disorder Act of 2025](https://policyrisk.com/legislation/119-s-825)
- [119-sres-913: A resolution relating to the death of the Honorable Nancy Kassebaum, former Uni…](https://policyrisk.com/legislation/119-sres-913)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-s-1097 (as of 2026-08-11).